康躍科技(300391.SZ)2021年度淨利潤預增57.98%-136.97%
格隆匯1月28日丨康躍科技(300391.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤4000萬元-6000萬元,同比增長57.98%-136.97%;扣除非經常性損益後的淨利潤3300萬元-4900萬元,同比增長126.92%-236.94%。
報吿期內,公司歸屬於上市公司股東的淨利潤較上年同期增長較大的主要原因為:
1、自2020年12月開始湖北長江星醫藥股份有限公司(“長江星”)納入公司合併報表範圍(公司持有長江星52.75%股權),2021年度公司合併長江星的業績對公司歸屬於上市公司股東的淨利潤影響額預計為1.1億元至1.4億元。
2、報吿期內,受市場激烈競爭、原材料上漲等因素影響,公司內燃機零部件板塊業務和光伏設備板塊業務淨利潤較上年同期有所下滑。
3、報吿期內,公司非經常性損益對淨利潤的影響金額約700萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.